Participating Faculty

Best Practices for Optimal Outcomes in the Treatment of Diabetes

This supplement to The American Journal of Managed Care reviews the burden of type 2 diabetes, overcoming obstacles to its effective care, and integrating clinical needs with medical policy and practice.

Faculty

William B. Bunn III, MD, JD, MPH

Vice President

Health, Safety, Security, and Productivity

Navistar, Inc

Warrenville, Illinois

R. Keith Campbell, RPh, FASHP, FAPhA, CDE

Distinguished Professor in Diabetes Care/Pharmacotherapy

College of Pharmacy

Washington State University

Pullman, Washington

Allan Jay Kogan, MD, MSS, ABFP, FAAFP, CPE

Medical Director, West Region

Department of Medical Management

CIGNA/Great West Healthcare

Dallas, Texas

Teresa M. Martin, RD, LD, CDE

Clinical Educator

Bend, Oregon

Faculty Disclosures

The faculty reported relationships with the following organizations:

and

William B. Bunn III, MD, JD, MPH, Keith Campbell, RPh, FASHP, FAPhA, CDE, Allan Jay Kogan, MD, MSS, ABFP, FAAFP, CPE, Teresa M. Martin, RD, LD, CDE

, have nothing to disclose relative to this activity.

Planning Committee Disclosures

Independent medical writers Mary Mihalovic and Judy Dyrud, and the staff of Pharmacy Times Office of Continuing Professional Education and The American Journal of Managed Care have nothing to disclose relative to this activity.

Continuing Education

Best Practices for Optimal Outcomes in the Treatment of Diabetes

GOAL

To provide participants with information about the causes and medical and economic consequences of type 2 diabetes and to provide strategies for treatment and management of patients.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of managed care professionals, family medicine, internal medicine, and pharmacists involved in the management of patients with type 2 diabetes.

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

•

Describe the burden of type 2 diabetes with respect to payer, provider, and patient

•

Establish the importance of effectively treating type 2 diabetes, citing current standards of care

•

Describe the achievement of treatment goals for patients with type 2 diabetes

•

Identify barriers to care related to reaching glycemic goals focusing on payer, provider, and patient issues

• Discuss next steps for "best practices" in the care of diabetes, integrating successful programs with current treatment guidelines and treatment options

TYPE OF CE ACTIVITY

Knowledge-based

Continuing PHARMACY Education ACCREDITATION

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 3.0 contact hours (0.3 CEUs) under the ACPE universal program number of 0290-0000-09-013-H01-P.

Release Date: September 1, 2009

Expiration Date: August 31, 2011

Funding

Merck & Co. Inc.

This supplement has been supported by an educational grant from

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Download PDF: Participating Faculty